Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates ADPT Bullish with a Setup Score of 0, net conviction 40, actionability 0. How the Setup Score works →
Total Setup Score
0
Directional Bias
Bullish
Net Conviction
40
Actionability
0 (extended)
Key signals behind this score
40wk Uptrend — rising+above (sma 16.06 vs px 21.80)
80wk Uptrend — rising+above (sma 12.93 vs px 21.80)
200wk Uptrend — rising+above (sma 8.66 vs px 21.80)
Funds Accumulating — momZ +0.42 · 3.16→3.26
Short Squeeze Setup — velZ +1.24 · age 103w×0.45 · 6.11%
Founder-Led — founder/CEO led
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Diagnostics & Research
Exchange: NASDAQ
IPO Date: June 27, 2019
Headquarters: 1165 Eastlake Avenue East, Seattle, WA, United States, 98109
Founder-Led: Yes — Chad Robins (Co-Founder, CEO & Chairman), Harlan Robins (Co-Founder & Chief Scientific Officer)
Key Metrics
Current Price
$21.06
Market Cap
$3.49B
Float
125.2M
Shares Outstanding
160.0M
Price/Sales (TTM)
11.81
vs. Analyst Target
-2.3% to analyst PT
Profit Margin
-16.82%
Operating Margin (TTM)
-27.10%
Revenue (TTM)
$295M
Dividend Rate
None
Analyst Target Price
$20.57 (8 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$98.4M
-$146M
$75.9M
-$144M
2021
$154M
-$207M
$105M
-$193M
2022
$185M
-$200M
$127M
-$175M
2023
$170M
-$225M
$94.7M
-$189M
2024
$179M
-$159M
$107M
-$129M
2025
$277M
-$59.5M
$206M
-$29.8M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
$58.9M
-$25.6M
Sep 2025
$94.0M
$9.5M
Dec 2025
$71.7M
-$13.6M
Mar 2026
$70.9M
-$20.0M
Ownership & Float
Insider Ownership
1.8%
Institutional Ownership
96.1%
Short Float
6.1%
% of All Funds Holding
3.26%
Number of Funds Holding
268
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$17.09
Near-term / short-term trend
Weekly
40-Week SMA
$16.04
Medium-term trend
Weekly
80-Week SMA
$12.92
Cyclical trend (business cycle)
Weekly
200-Week SMA
$8.66
Secular trend (multi-year)
Monthly
10-Month SMA
$17.34
Near-term monthly trend
Monthly
20-Month SMA
$13.49
Medium-term monthly trend
Monthly
40-Month SMA
$9.27
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$15.00
support
1.77x
0 months ago
$12.90
support
1.05x
9 months ago
$10.10
support
1.22x
10 months ago
$9.60
support
1.27x
12 months ago
$7.50
support
1.59x
13 months ago
Historical Earnings Reactions (29 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.73%
0.38%
55.17%
19.70%
-10.72%
1 Day
2.59%
0.95%
62.07%
33.70%
-18.18%
1 Week
-1.34%
-0.46%
48.28%
22.69%
-25.62%
2 Weeks
-3.14%
-1.73%
48.28%
22.96%
-31.89%
1 Month
-1.36%
-1.32%
46.43%
35.60%
-36.19%
Next earnings: August 4, 2026 (24 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
-0.6%
42.9%
7
Feb
-3.4%
42.9%
7
Mar
-10.8%
14.3%
7
Apr
-8.4%
42.9%
7
May
10.4%
57.1%
7
Jun
14.5%
85.7%
7
Jul
-0.1%
42.9%
7
Aug
7.4%
57.1%
7
Sep
-6.6%
42.9%
7
Oct
-3.0%
28.6%
7
Nov
4.9%
71.4%
7
Dec
3.2%
71.4%
7
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.02%
51.4%
331
Tuesday
0.04%
49.9%
365
Wednesday
0.31%
50.4%
361
Thursday
0.04%
46.5%
353
Friday
-0.02%
46.2%
353
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 96.1%
Insider Transactions — Smart Summary
Total insider ownership: 1.8%
Founder-led management: Chad Robins (Co-Founder, CEO & Chairman), Harlan Robins (Co-Founder & Chief Scientific Officer)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Adaptive Biotechnologies Corp
(ADPT) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.